Walleye Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Walleye Capital's GILD Position: Q1 2026 in Review
Walleye Capital increased its Gilead Sciences (GILD) stake by 552% in Q1 2026, buying an estimated $17.9M and bringing the position to 150,967 shares worth $21M. The position accounts for 0.09% of the portfolio, ranked #179.
Walleye Capital first reported a position in GILD in Q1 2019 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Walleye Capital held 150,967 shares of Gilead Sciences worth $21M as of Q1 2026.
- Walleye Capital bought 127,817 Gilead Sciences shares in Q1 2026, an estimated $17.9M.
- Gilead Sciences made up 0.09% of Walleye Capital's portfolio in Q1 2026, its #179 holding.
- Walleye Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 14 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.